These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 2995647

  • 21. Effects of a thromboxane synthetase inhibitor and a cAMP phosphodiesterase inhibitor, singly and in combination, on platelet behaviour.
    Sills T, Heptinstall S.
    Thromb Haemost; 1986 Jun 30; 55(3):305-8. PubMed ID: 3018954
    [Abstract] [Full Text] [Related]

  • 22. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
    Zahavi M, Zahavi J, Kakkar VV.
    Thromb Haemost; 1984 Oct 31; 52(2):205-9. PubMed ID: 6098048
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of platelet aggregation by olive oil phenols via cAMP-phosphodiesterase.
    Dell'Agli M, Maschi O, Galli GV, Fagnani R, Dal Cero E, Caruso D, Bosisio E.
    Br J Nutr; 2008 May 31; 99(5):945-51. PubMed ID: 17927845
    [Abstract] [Full Text] [Related]

  • 24. Antithrombotic activity of SR 46349, a novel, potent and selective 5-HT2 receptor antagonist.
    Herbert JM, Bernat A, Barthelemy G, Dol F, Rinaldi M.
    Thromb Haemost; 1993 Mar 01; 69(3):262-7. PubMed ID: 8470049
    [Abstract] [Full Text] [Related]

  • 25. Synergistic antiplatelet effect of ridogrel, a combined thromboxane receptor antagonist and thromboxane synthase inhibitor, and UDCG-212, a cAMP-phosphodiesterase inhibitor.
    Hoet B, Arnout J, Deckmyn H, Vermylen J.
    Thromb Haemost; 1993 Nov 15; 70(5):822-5. PubMed ID: 8128441
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Pharmacology of a potent, new antithrombotic agent, 1,3-dihydro-7,8-dimethyl-2H-imidazo[4,5-b]quinolin-2-one (BMY-20844).
    Buchanan JO, Fleming JS, Cornish BT, Baryla UM, Gillespie E, Stanton HC, Seiler SM, Keely SL.
    Thromb Res; 1989 Nov 01; 56(3):333-46. PubMed ID: 2559492
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Potent effects of novel anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme activity.
    Sudo T, Tachibana K, Toga K, Tochizawa S, Inoue Y, Kimura Y, Hidaka H.
    Biochem Pharmacol; 2000 Feb 15; 59(4):347-56. PubMed ID: 10644042
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Platelet cyclic 3':5'-nucleotide phosphodiesterase released by thrombin and calcium ionophore.
    Hidaka H, Asano T.
    J Biol Chem; 1976 Dec 10; 251(23):7508-16. PubMed ID: 187590
    [Abstract] [Full Text] [Related]

  • 34. In vitro and in vivo inhibitory effects of propentofylline on cyclic AMP phosphodiesterase activity.
    Nagata K, Ogawa T, Omosu M, Fujimoto K, Hayashi S.
    Arzneimittelforschung; 1985 Dec 10; 35(7):1034-6. PubMed ID: 2996562
    [Abstract] [Full Text] [Related]

  • 35. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
    Merritt JE, Hallam TJ, Brown AM, Boyfield I, Cooper DG, Hickey DM, Jaxa-Chamiec AA, Kaumann AJ, Keen M, Kelly E.
    Br J Pharmacol; 1991 Jan 10; 102(1):251-9. PubMed ID: 1710526
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Lithium inhibits adenylate cyclase of human platelets.
    Imandt L, Tijhuis D, Wessels H, Haanen C.
    Thromb Haemost; 1981 Apr 30; 45(2):142-5. PubMed ID: 6266068
    [Abstract] [Full Text] [Related]

  • 40. Cyclic 3',5'-adenosine monophosphate in human blood platelets. II. Effect of N6-2'-o-dibutyryl cyclic 3',5'-adenosine monophosphate on platelet function.
    Salzman EW, Levine L.
    J Clin Invest; 1971 Jan 30; 50(1):131-41. PubMed ID: 4322665
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.